Locations
 
WEBSITES
  • United States
  • International
  • Japan
 
  • Investor Relations
  • IMPACT Online
  • Home
  • Products
     
    U.S. ProductsView International Products
    Devices
    Surgical and Diagnostic Devices
    • cardioPAT
    • Cell Saver 5+
    • Cell Saver Elite
    • OrthoPAT
    • SmartSuction Harmony
    • TEG 5000
    Blood and Plasma Center Devices
    • ACP 215
    • Cymbal
    • MCS+ 8150
    • MCS+ 9000
    • PCS 2
    • SEBRA Sealers
    Software
    Blood Center Software
    • Donor Doc
    • eDonor
    • ElDorado Donor
    • eLynx
    • Hemasphere
    • Surround
    Hospital Software
    • BloodTrack
    • EdgeCell
    • ElDorado Control
    • SafeTrace Tx
    Plasma Center Software
    • Cash Card
    • DMS
    • eLynx
    • eQue
    • Logic
    • NextGen
    Services
    Consulting Services
    • Education and Change Management
    • IMPACT Online
    • Process Improvement
    Software Services
    • Software Services Overview
    • Client Support
    • Education Services
    • Implementation Services
    • Remote Hosting Services
    • Technical Services
    • Validation Services
     
  • Solutions
     
    Blood Management Solutions
    • Solutions for Blood Centers
    • Solutions for Hospitals
    • Solutions for Plasma Centers
     
  • Learning Center
     
    Product Training
    • All Products
    • Blood Centers
    • Hospitals
    • Plasma Centers
    Thought Leadership
    • Poster Abstracts
    • White Papers & Clinical Reviews
    • Reference Lists
    Education
    • Clinical Leadership
    • Presentations
     
  • About Haemonetics
     
    Company Background
    • Overview
    • Historical Timeline
    • Leadership Team
    • Office Locations
    Investor Relations
    • Investor Relations Home
    • Stock Information
    • Earnings
    • Forecasts & Guidance
    News & Events
    • In the News
    • Calendar of Events
    Careers
    • Careers Overview
    • Benefits Overview
    • Employee Spotlight
     
  • Customer Support
  • Home
  • Learning Center
  • Thought Leadership
  • Poster Abstracts
  • Contact Us
  • Print
  • Share

Poster Abstracts

  • The use and misuse of fresh frozen plasma: an analysis of 26,637 transfusion recipients

    AABB 2011

    Methods: We analyzed over three years of patient specific transfusion data from 29 US hospitals using the IMPACT Online database (Haemonetics, Braintree, MA). 26,637 patients who received 135,149 units of FFP were identified. Data was analyzed by dosage and by recipient age. View document

  • Appropriateness of red cell transfusion for patients with gastro-intestinal bleeding

    SABM 2011

    Methods: We analyzed over three years of patient specific transfusion data from 29 US hospitals using the IMPACT® Online database (Haemonetics, Braintree, MA). 13,407 patients with upper GIB and 6,772 with lower GIB who had endoscopy as part of their hospital treatment were identified. View document

  • Patterns of transfusion in obstetrical patients: information from the IMPACT® Online database

    SABM 2011

    Introduction: Little is known about current status of transfusion in obstetrical patients. We sought to understand the potential opportunities for improving blood management by analyzing transfusion data from a large number of patients having both vaginal and Caesarian deliveries. View document

  • The influence of comorbidity on red cell transfusions for patients with upper gastro-intestinal bleeding

    SABM 2011

    Methods: Final hemoglobin for patients receiving a transfusion, defined as the last recorded hemoglobin prior to discharge, was included in the analysis as an indicator of transfusion practice. We looked at age, percent transfused, units transfused, and final hemoglobin of transfused patients in separate cohorts of CCI to determine if there was a correlation between the CCI and transfusion practice. View document

  • By how much does a single unit transfusion increase the recipient’s hemoglobin?

    AABB 2010

    Methods: The effect of a single unit RBC transfusion on the recipient’s Hgb was measured in 113 patients who received only one unit of stored RBC (allogeneic or predonated autologous) during their hospital stay. Only patients who had both pre and post-transfusion measurements were included and we selected only those patients who were transfused on postoperative day 2 or 3 to eliminate the confounding variables of ongoing blood loss and/or infusion of shed blood. View document

  • Post-operative blood salvage with cell washing reduces stored blood transfusion for patients having joint replacement surgery

    SABM 2010

    Conclusion: The implementation of post-operative blood salvage with cell washing (OrthoPAT) resulted in the recovery of more than one unit of red cells per patient and reduced stored blood use by 48%. Post-operative salvage should be considered a first-line transfusion strategy in joint replacement surgery. View document

  • AABB 2010 poster abstract
  • Final hemoglobin – a proposed metric for understanding the “transfusion trigger”

    SABM 2010

    Results: As shown in the table, Hospital A’s allogeneic transfusion rate (34%) is lower than that of Hospital B (42%). The final hemoglobin metric reveals that the lower rate was achieved (at least in part) by adopting a lower hemoglobin trigger for RBC transfusion since Hospital A’s transfused patients were discharged with lower final hemoglobin values than transfused patients at Hospital B. "Over transfusion" in Hospital B is suggested by the fact that half of their transfused patients were discharged with a final hemoglobin > 10g/dL. View document

  • Contact Us
  • Terms of Use
  • Quality
  • Careers
  • Privacy Policy
  • Site Map

© 2012 • Haemonetics Corporation • 400 Wood Road • Braintree • MA • 02184 Website Feedback